Promoter encumbrance reasons disclosed under SEBI SAST regulations

Ownership Changes View source PDF Explain this filing

COHANCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.9%Reaction day

₹414.10

prior close

₹410.00

announcement price

After-mkt

timing

Nifty Smallcap 250market+0.6%-2.5% vs market

Pharmaceuticals peers, median of 160sector+0.4%-2.3% vs sector

On the reaction day the stock moved 2.5 pts less than Nifty Smallcap 250 and 2.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

-0.3

15m

-0.6

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.9+0.6-2.5+0.4-2.3

Next day

-2.4+1.3-3.8+0.5-3.0

+10.4+0.8+9.6+1.7+8.7

+11.1+1.0+10.1+1.7+9.4

+10.3+0.5+9.7+0.9+9.3

+8.7+0.0+8.6+1.5+7.2

+8.9+1.1+7.8+2.7+6.2

15d

+8.3+3.2+5.1+4.1+4.2

+8.5+2.3+6.1+4.0+4.5

+7.4+3.5+3.9+2.0+5.4

+10.6+3.8+6.9+7.7+3.0

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

BSE has received a disclosure from the promoter of Cohance Lifesciences Ltd detailing the reasons for encumbrance (pledge) on the promoters shares, filed under Regulation 31(1) read with Regulation 28(3) of the SEBI SAST Regulations, 2011. Such disclosures are mandatory when promoters create, modify, or release pledges on their holdings, explaining the purpose and financial context.

Likely market impact

Monitor the detailed filing for pledge quantum and reason. Invocation or large new pledges can pressure the stock, while releases are neutral to positive.